Purpose In the present report we describe our clinical experience using specific image-
based decision making and anatomic considerations for transcatheter valve-in-valve (ViV) …

OBJECTIVES: This study evaluates reinterventions for degenerated stentless aortic
xenografts. METHODS: Between 2010 and 2015, 52 consecutive patients (age 72.3±9.7 …

The valve-in-valve (ViV) procedure is an option for patients with symptomatic structural
degeneration of a bioprosthesis and excessive reoperative risk. The risk of coronary …

Aims: Recently, the feasibility of valve-in-valve procedures using current first-generation
transcatheter heart valves (THV) in cases of structural valve degeneration has been reported …

Background Valve-in-valve (ViV) procedures for degenerated bioprostheses are an
alternative for the standard of care in an aging population. Several reports showed that the …

Objectives Bioprostheses with pericardial leaflets mounted externally on the stent pose a
high risk for valve‐in‐valve (ViV) procedures. This study analyzed the efficacy and safety of …

1998 Circulation December 2, 2014 echocardiogram was used to follow up these patients,
and an increased gradient and valve insufficiency were used as the criteria for SVD. Only …

OBJECTIVES To assess the feasibility and results of 'valve-in-valve'implantation using the
23-mm CoreValve for the treatment of degenerated 19-mm and 21-mm Mitroflow …

Background Valve-in-valve transcatheter aortic valve implantation for degenerated aortic
bioprostheses is an effective option for patients at high risk for redo surgery, even if it may be …

BACKGROUND: The reoperative risk for degenerated aortic valve xenografts may be
increased in elderly patients with comorbidities. We evaluated the off-pump beating heart …